- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Rezolute Inc (RZLT)
The Rezolute share price today is 3.090, view NASDAQ RZLT stock exchange data. Track the latest Rezolute share price with real-time updates on RZLT stock performance including market cap, day range, 52-week range and dividend yield. Access RZLT charts, earnings dates and analyst estimates to support your investment decisions.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.000
3.157
52 wk Range
1.070
11.457
Earnings results expected in 5 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.0003.157
52 wk Range
1.07011.457
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RZLT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
5.125
Upside
+65.86%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
4 analysts have revised their earnings downwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
7 Buy
3 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 5.125
(+65.86% Upside)
Rezolute Inc SWOT Analysis
Pipeline Progress | Explore Rezolute's promising clinical trials for ersodetug in hyperinsulinism and RZ402 for diabetic macular edema, with key results expected in 2025-2026. |
Financial Strength | Delve into Rezolute's robust financial position, with $118 million in cash and a strong current ratio, supporting ongoing clinical programs. |
Market Opportunities | Learn about Rezolute's potential in niche markets, including congenital hyperinsulinism and diabetic macular edema, with oral administration as a key advantage. |
Analyst Outlook | Discover varied analyst perspectives on Rezolute, with price targets ranging from $7 to $9, reflecting the company's growth potential in metabolic diseases. |
Earnings
Latest Release
12-02-2026
EPS / Forecast
-0.22 / -0.19
Revenue / Forecast
-- / --
Compare RZLT to Peers and Sector
Metrics to compare | RZLT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRZLTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.8x | −3.1x | −0.6x | |
PEG Ratio | −0.17 | −0.05 | 0.00 | |
Price/Book | 2.5x | 6.0x | 2.6x | |
Price / LTM Sales | - | 19.6x | 3.2x | |
Upside (Analyst Target) | 59.2% | 78.5% | 48.1% | |
Fair Value Upside | Unlock | 0.2% | 5.8% | Unlock |
Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Rezolute (RZLT) Share Price Today?
The Rezolute share price today is 3.090.
What is the current Rezolute (RZLT) share price and day range?
As of 08-05-2026, the Rezolute share price is 3.090, with a previous close of 3.140. The share price has ranged from 3.000 to 3.157 today, while the 52-week range spans from 1.070 to 11.457.
What Is the Rezolute Market Cap?
As of today, Rezolute market cap is 320.450M.
What Is the Rezolute (RZLT) Share Price Target?
The average 12-month share price target for Rezolute is 5.125, with a high estimate of 6 and a low estimate of 4. 7 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +65.86% Upside potential.
What Is Rezolute's Earnings Per Share (TTM)?
The Rezolute EPS (TTM) is -0.908.
When Is the Next Rezolute Earnings Date?
Rezolute will release its next earnings report on 13-05-2026.
From a Technical Analysis Perspective, Is RZLT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Rezolute Trade On?
Rezolute is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Rezolute?
The stock symbol for Rezolute is "RZLT."
How Many Times Has Rezolute Stock Split?
Rezolute has split 3 times.
How Many Employees Does Rezolute Have?
Rezolute has 75 employees.
What Is the RZLT Premarket Price?
RZLT's last pre-market stock price is 3.124. The pre-market share volume is 3,420.000, and the stock has changed by -0.016, or -0.510%.
What Is the RZLT After Hours Price?
RZLT's last after hours stock price is 3.089, the stock has changed by -0.001, or -0.030%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.